{"id":64175,"date":"2025-01-30T12:01:27","date_gmt":"2025-01-30T12:01:27","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/01\/30\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/"},"modified":"2025-01-30T12:01:27","modified_gmt":"2025-01-30T12:01:27","slug":"kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/","title":{"rendered":"Kymera Therapeutics to Participate in Upcoming February Investor Conferences"},"content":{"rendered":"<div>\n<p align=\"left\">WATERTOWN, Mass., Jan.  30, 2025  (GLOBE NEWSWIRE) &#8212; <strong>\u00a0<\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=k985LEB3SBsAVBZI_VPkWpe92yfo5z8A38jJ5etQl4XxPrGbnT0N4htyns8qMRZPHJ-UV9G_btEJYx0IksrKwV_jPC4am_nEYbOaBYJWrOw=\" rel=\"nofollow\" target=\"_blank\" title=\"Kymera Therapeutics, Inc.\">Kymera Therapeutics, Inc.<\/a> (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines with biologics-like activity for immunological diseases, today announced that the Company will participate in fireside chats at the following upcoming investor events:<\/p>\n<ul type=\"disc\">\n<li>Guggenheim SMID Cap Biotechnology Conference in New York, NY on February 6 at 10:00 a.m. ET; and<\/li>\n<li>Oppenheimer 35<sup>th<\/sup> Annual Healthcare Life Sciences Conference held virtually on February 11 at 11:20 a.m. ET.<\/li>\n<\/ul>\n<p>Live webcasts of the presentations will be available under \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zU_qGhB3EkwqA2CtcUOnhlvHzIvNhjyKKhOeYTLwCWO_GZswIKD5y_PVqlM7UkH1cmXPI9l9B1SUsqR9YfkSgF37wS5qiwotj_Db5-aLer1LjuVL4_t1oaSbeyHJwbkh\" rel=\"nofollow\" target=\"_blank\" title=\"News and Events\">News and Events<\/a>\u201d in the Investors section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WZAv444k3nbP6nqNPPCOLsgyNmSF6R6ibzH6o6Jm1oPpUF0_OXWOpzZ1VzoZd10voV7PbT_JJ7uKjzzcQANE_g==\" rel=\"nofollow\" target=\"_blank\" title=\"www.kymeratx.com\">www.kymeratx.com<\/a>. Replays of the webcasts will be archived and available following the events.<\/p>\n<p><strong>About Kymera Therapeutics<\/strong><br \/>Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients\u2019 lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston\u2019s top workplaces for the past several years. For more information about our science, pipeline and people, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WZAv444k3nbP6nqNPPCOLhnI0FbwP3WwfuYDwR-55LHL2DGtmdHPHtbeHq7ea0XoJ8nufm0Ei29ZUiWLSwiAQg==\" rel=\"nofollow\" target=\"_blank\" title=\"www.kymeratx.com\">www.kymeratx.com<\/a> or follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AM8gZ7OQxHv2oPFXWXEXgOOzStEGjUprsnxB8KJa0QRFRRnlLV3fYwvnlBTZilOwlK1LWvE4CAy9b5t-4ATLeg==\" rel=\"nofollow\" target=\"_blank\" title=\"X\">X<\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jmm3_C6L91-5j11CrWCwCIyYnpyzC01d1PLz9ossX5HCIMqk1c-yeuTtrXxCnhSTWQW16Jayd67ZfKa8dQ2Swn4T0tCO1aIJ3v4AxNE_va800Rd6JDP3mTmWP3GWFwdQ\" rel=\"nofollow\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a>.<\/p>\n<p><strong>Investor and Media Contact:<\/strong>\u00a0<\/p>\n<p>Justine Koenigsberg<br \/>Vice President, Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DEtybjX2Da4HElBB6K_18ZogOsRu8BjN7M9V0_BvZ4niI4AJHNqYDNUJfR_lD0vkcfoiOoFLui7iaq3-UsGR4M4KbuXWThF-2dB8vhQ7xFY=\" rel=\"nofollow\" target=\"_blank\" title=\"investors@kymeratx.com\">investors@kymeratx.com<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bUpz911udsQG6_rfjJfLf1zTlL0Z-iwk6o2QqVVkaXHWvGNLoCUj-DFGDLiPalA4SD0U4gp8qoSFkPPILrOyUX2tKU0V4noAYZuzxPIsHsg=\" rel=\"nofollow\" target=\"_blank\" title=\"media@kymeratx.com\">media@kymeratx.com<\/a> <br \/>857-285-5300<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDY4MTlhNGQtZmNhMC00YTY1LWJmYTktYmU2NjA0NTRlNDBhLTEyMTIzODU=\/tiny\/Kymera-Therapeutics-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WATERTOWN, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) &#8212; \u00a0Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines with biologics-like activity for immunological diseases, today announced that the Company will participate in fireside chats at the following upcoming investor events: Guggenheim SMID Cap Biotechnology Conference in [&#8230;]\n","protected":false},"author":1,"featured_media":64176,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-64175","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Kymera Therapeutics to Participate in Upcoming February Investor Conferences - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kymera Therapeutics to Participate in Upcoming February Investor Conferences\" \/>\n<meta property=\"og:description\" content=\"WATERTOWN, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) &#8212; \u00a0Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advanc\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-30T12:01:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/01\/Kymera-Therapeutics-Inc-1-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Kymera Therapeutics to Participate in Upcoming February Investor Conferences\",\"datePublished\":\"2025-01-30T12:01:27+00:00\",\"dateModified\":\"2025-01-30T12:01:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/\"},\"wordCount\":267,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/\",\"name\":\"Kymera Therapeutics to Participate in Upcoming February Investor Conferences - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-01-30T12:01:27+00:00\",\"dateModified\":\"2025-01-30T12:01:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kymera Therapeutics to Participate in Upcoming February Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Kymera Therapeutics to Participate in Upcoming February Investor Conferences - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Kymera Therapeutics to Participate in Upcoming February Investor Conferences","og_description":"WATERTOWN, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) &#8212; \u00a0Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advanc","og_url":"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-01-30T12:01:27+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/01\/Kymera-Therapeutics-Inc-1-2.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Kymera Therapeutics to Participate in Upcoming February Investor Conferences","datePublished":"2025-01-30T12:01:27+00:00","dateModified":"2025-01-30T12:01:27+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/"},"wordCount":267,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/","url":"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/","name":"Kymera Therapeutics to Participate in Upcoming February Investor Conferences - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-01-30T12:01:27+00:00","dateModified":"2025-01-30T12:01:27+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/kymera-therapeutics-to-participate-in-upcoming-february-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Kymera Therapeutics to Participate in Upcoming February Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64175","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=64175"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64175\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/64176"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=64175"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=64175"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=64175"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}